Carlsmed Inc. is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions. Carlsmed Inc. is based in CARLSBAD, Calif.
| Revenue (Most Recent Fiscal Year) | $50.51M |
| Net Income (Most Recent Fiscal Year) | $-29.63M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 5.15 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.62 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -58.67% |
| Net Margin (Trailing 12 Months) | -58.67% |
| Return on Equity (Trailing 12 Months) | -72.60% |
| Return on Assets (Trailing 12 Months) | -27.93% |
| Current Ratio (Most Recent Fiscal Quarter) | 8.87 |
| Quick Ratio (Most Recent Fiscal Quarter) | 8.74 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.16 |
| Inventory Turnover (Trailing 12 Months) | 8.80 |
| Book Value per Share (Most Recent Fiscal Quarter) | $3.72 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.32 |
| Earnings per Share (Most Recent Fiscal Year) | $-2.12 |
| Diluted Earnings per Share (Trailing 12 Months) | $-3.66 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 26.73M |
| Free Float | -- |
| Market Capitalization | $260.10M |
| Average Volume (Last 20 Days) | 0.11M |
| Beta (Past 60 Months) | -- |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |